Interaction of metabolic and haemodynamic factors in mediating experimental diabetic nephropathy

2001/11/01 by Mark E. Cooper, M. E. Cooper · 26 citations
Medicine · Biochemistry, Genetics and Molecular Biology · #Chronic Kidney Disease and Diabetes #Advanced Glycation End Products research #Microbial metabolism and enzyme function

paper · pdf · doi:10.1007/s001250100000

Cited by

• Cellular and humoral immune responses in the early stages of diabetic nephropathy in NOD mice
• Advanced glycation end products activate a chymase-dependent angiotensin II-generating pathway in diabetic complications. [europepmc]
• New insights into the importance of aminopeptidase A in hypertension. [europepmc]
• Therapies for hyperglycaemia-induced diabetic complications: from animal models to clinical trials. [europepmc]
• Poly(ADP-ribose) polymerase (PARP) inhibition counteracts multiple manifestations of kidney disease in long-term streptozotocin-diabetic rat model. [europepmc]
• Oxidative stress in diabetic nephropathy. [europepmc]
• Heat-processed Panax ginseng and diabetic renal damage: active components and action mechanism. [europepmc]
• MicroRNA in diabetic nephropathy: renin angiotensin, aGE/RAGE, and oxidative stress pathway. [europepmc]
• Renoprotective, anti-oxidative and anti-apoptotic effects of oral low-dose quercetin in the C57BL/6J model of diabetic nephropathy. [europepmc]
• TNF-α and microalbuminuria in patients with type 2 diabetes mellitus. [europepmc]
• Diabetic nephropathy: What does the future hold? [europepmc]
• Advanced glycation end products (AGEs) promote melanogenesis through receptor for AGEs. [europepmc]
• Effects of astragalosides from Radix Astragali on high glucose-induced proliferation and extracellular matrix accumulation in glomerular mesangial cells. [europepmc]
• Aortic Stiffness as a Surrogate Endpoint to Micro- and Macrovascular Complications in Patients with Type 2 Diabetes. [europepmc]
• T2DiACoD: A Gene Atlas of Type 2 Diabetes Mellitus Associated Complex Disorders. [europepmc]
• Diabetic Nephropathy: a Tangled Web to Unweave. [europepmc]
• Treatment effects of renin-angiotensin aldosterone system blockade on kidney failure and mortality in chronic kidney disease patients. [europepmc]
• Glucose and Blood Pressure-Dependent Pathways-The Progression of Diabetic Kidney Disease. [europepmc]
• The Potential of Albuminuria as a Biomarker of Diabetic Complications. [europepmc]
• Wogonin Ameliorates Renal Inflammation and Fibrosis by Inhibiting NF-κB and TGF-β1/Smad3 Signaling Pathways in Diabetic Nephropathy. [europepmc]
• Potential Targeting of Renal Fibrosis in Diabetic Kidney Disease Using MicroRNAs. [europepmc]
• Fibrosis in Chronic Kidney Disease: Pathogenesis and Consequences. [europepmc]
• Wnt5a promotes renal tubular inflammation in diabetic nephropathy by binding to CD146 through noncanonical Wnt signaling. [europepmc]
• Epidermal Growth Factor Receptor: A Potential Therapeutic Target for Diabetic Kidney Disease. [europepmc]
• The CREB/KMT5A complex regulates PTP1B to modulate high glucose-induced endothelial inflammatory factor levels in diabetic nephropathy. [europepmc]
• Could Systemic Inflammatory Index Predict Diabetic Kidney Injury in Type 2 Diabetes Mellitus? [europepmc]